Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group

Human Molecular Genetics
Nadem SoufirB Bressac-de Paillerets

Abstract

Germline mutations in the p16 and CDK4 genes have been reported in a subset of melanoma pedigrees, but their prevalence is not well known. We searched for such germline mutations in 48 French melanoma-prone families selected according to two major criteria: families with at least three affected members (n = 20) or families with two affected members, one of them affected before the age of 50 (n = 28), and one additional minor criterion. Sixteen different p16 germline mutations were found in 21 families, while one germline mutation, Arg24His, was detected in the CDK4 gene. The frequency of p16 gene mutation in our sample (44%) is among the highest rates yet reported and the CDK4 mutation is the second mutation detected in this gene worldwide. In summary, our results show frequent involvement of the p16 gene in familial melanoma and confirm the role of the CDK4 gene as a melanoma-predisposing gene.

Citations

Mar 30, 2000·International Journal of Cancer. Journal International Du Cancer·S BirindelliS Pilotti
Feb 23, 2000·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·M Q Islam, K Islam
Jun 22, 2000·Genes, Chromosomes & Cancer·I SaurojaS Pyrhönen
May 10, 2002·Cancer·M Anne BlackwoodArupa Ganguly
Jul 31, 2001·Genes, Chromosomes & Cancer·P M PollockN K Hayward
Jun 1, 2011·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Emmanuelle BourneufSilvia Vincent-Naulleau
Jul 9, 2009·Human Genetics·Kathrine Damm Meyle, Per Guldberg
Jul 13, 2007·Familial Cancer·Christian MonneratBrigitte Bressac-de Paillerets
Dec 21, 2000·Current Oncology Reports·N Hayward
May 26, 2005·Biochemical and Biophysical Research Communications·T M BeckerG J Mann
Feb 15, 2005·Clinics in Dermatology·Brian SomoanoHensin Tsao
Jan 26, 2002·Lancet·Graeme J Walker, Nicholas K Hayward
Mar 20, 2002·Biochimie·Brigitte Bressac-de-PailleretsFlorence Demenais
Oct 15, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S GuérinF de Vathaire
Dec 3, 2003·Oncogene·Paula L Miliani de MarvalMarcelo L Rodriguez-Puebla
Aug 14, 2002·The British Journal of Dermatology·J E Osborne, P E Hutchinson
Jan 10, 2003·The Journal of Investigative Dermatology. Symposium Proceedings·Andrzej DlugoszStuart H Yuspa
Aug 8, 1998·The New England Journal of Medicine·J C Bystryn
Mar 10, 1999·Journal of the National Cancer Institute·J AitkenN Hayward
Mar 16, 2000·Journal of the National Cancer Institute·V BatailleT D Spector
Oct 20, 2005·Journal of the National Cancer Institute·Colin B BeggUNKNOWN Genes Environment and Melanoma Study Group
Feb 26, 2003·Current Opinion in Oncology·Richard F Kefford, Graham J Mann
Feb 8, 2006·Current Opinion in Oncology·Lana PhoSancy A Leachman
Nov 21, 2007·Cancer Nursing·Meg R GerstenblithMary C Fraser
Jun 5, 2012·Genes & Development·Hensin TsaoDavid E Fisher
Mar 28, 2008·Pigment Cell & Melanoma Research·S MajoreP Grammatico
Nov 6, 2008·Pigment Cell & Melanoma Research·L PastorinoG Bianchi Scarrà
Dec 15, 2010·Pigment Cell & Melanoma Research·Sandy GiulianoCorine Bertolotto
Feb 7, 2013·Journal of Medical Genetics·Hanne Eknes PuntervollAnders Molven
Sep 20, 2005·Journal of Medical Genetics·K B NiendorfH Tsao
Aug 15, 2006·Journal of Medical Genetics·Alisa M GoldsteinUNKNOWN Melanoma Genetics Consortium (GenoMEL)
Jan 8, 2008·Journal of Medical Genetics·A M GoldsteinK Stefansson
Jul 24, 2013·Annual Review of Genomics and Human Genetics·Victoria K HillAlisa M Goldstein
Apr 30, 2009·Annual Review of Pathology·Nageatte Ibrahim, Frank G Haluska
Nov 18, 2003·Journal of Carcinogenesis·Peter MeyerClaus Garbe
Jan 1, 2004·Hereditary Cancer in Clinical Practice·Tadeusz Debniak
Apr 12, 2011·PloS One·Smruti J VidwansJeff Shrager
Apr 20, 2014·PloS One·Yoana Arroyo-BerdugoMaría Dolores Boyano
Nov 5, 2003·Pharmacogenomics·Christopher HullSancy Leachman
Apr 25, 2000·Drugs·H H Sedlacek
Aug 26, 2004·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Ann E Barker-Griffith, Barbara W Streeten

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.